{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:20:00Z","timestamp":1787671200121,"version":"build-2736575974"},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T00:00:00Z","timestamp":1194912000000},"content-version":"vor","delay-in-days":3664,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:p>All adverse drug reaction reports labelled seizures or myoclonus during treatment with antidepressants and stored in the Swedish national database for spontaneous reporting of adverse drug reactions were reviewed in order to evaluate possible risk factors. The reporting physicians were contacted and asked for complementary information, and blood samples for determination of the <jats:italic>CYP2D6<\/jats:italic> and <jats:italic>CYP2C19<\/jats:italic> genotypes were obtained from patients available. In total, 25 cases of seizures and 7 cases of myoclonus were studied. The drugs included were maprotiline (<jats:italic>n<\/jats:italic>=8), mianserin (<jats:italic>n<\/jats:italic>=7), fluvoxamine (<jats:italic>n<\/jats:italic>=6), amitriptyline (<jats:italic>n<\/jats:italic>=3), clomipramine (<jats:italic>n<\/jats:italic>=3), citalopram (<jats:italic>n<\/jats:italic>=2), paroxetine (<jats:italic>n<\/jats:italic>=2) and lofepramine (<jats:italic>n<\/jats:italic>= 1). Previously suggested predisposing factors were identified in all but four cases (87%). None of the 11 patients genotyped were found to be poor metabolizers with respect to the enzymes CYP2D6 or CYP2C19. Thus, neither the <jats:italic>CYP2D6<\/jats:italic> nor the <jats:italic>CYP2C19<\/jats:italic> genotype were found to be associated with the occurrence of seizures\/myoclonus during treatment with antidepressants. However, 15 patients (47%) were concomitantly treated with drugs with potential inhibitory effects on CYP2D6, such as neuroleptics and dextropropoxyphene, and the patients might thus have been converted from the extensive metabolizer to the poor metabolizer phenotype during this treatment. Concomitant treatment with drugs decreasing the seizure threshold and\/or inhibiting the metabolism of antidepressants appeared to be an important risk factor for the occurrence of seizures\/myoclonus.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1997.tb09933.x","type":"journal-article","created":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T17:20:00Z","timestamp":1194974400000},"page":"379-384","source":"Crossref","is-referenced-by-count":43,"title":["Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors"],"prefix":"10.1111","volume":"96","author":[{"given":"O.","family":"Spigset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hedenmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010L.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.\u2010E.","family":"Wiholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,11,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(84)72920-3"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1992.tb02665.x"},{"key":"e_1_2_1_4_2","first-page":"321","volume-title":"Adverse effects of psychotropic drugs","author":"Schaul N","year":"1992"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700029354"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb01465.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563656908990950"},{"key":"e_1_2_1_8_2","first-page":"329","article-title":"Clozapineinduced myoclonic jerks and drop attacks","volume":"53","author":"Berman I","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.8.1069"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605030-00006"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00316090"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00415a010"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.193"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.2"},{"key":"e_1_2_1_15_2","first-page":"657","volume-title":"Pharmacogenetics of drug metabolism","author":"Wilkinson GR","year":"1992"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00173a017"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S\u2010mephenytoin in humans","volume":"269","author":"DeMorais SMF","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_1_18_2","first-page":"594","article-title":"Identification of a new genetic defect responsible for the polymorphism of (S)\u2010mephenytoin metabolism in Japanese","volume":"46","author":"DeMorais SMF","year":"1994","journal-title":"Mol Pharmacology"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92086-W"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199512000-00004"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199005020-00004"},{"key":"e_1_2_1_22_2","first-page":"139","volume-title":"Pharmacoepidemiology","author":"Wiholm B\u2010E","year":"1994"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199005010-00002"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198306000-00008"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.176"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00266363"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199506000-00010"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb03281.x"},{"key":"e_1_2_1_29_2","first-page":"197","article-title":"Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion","volume":"44","author":"Peck AW","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_30_2","first-page":"36","article-title":"Preliminary results from a multicenter trial of clomipramine in obsessive\u2010compulsive disorder","volume":"25","author":"De Veaugh\u2010Geiss J","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_31_2","first-page":"160","article-title":"Tricyclic antidepressant\u2010induced seizures and plasma drug concentration","volume":"53","author":"Preskorn SH","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198302000-00023"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674378302800710"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.197"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1997.tb09933.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1997.tb09933.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:17:56Z","timestamp":1698412676000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1997.tb09933.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1111\/j.1600-0447.1997.tb09933.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1997.tb09933.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}